HAP Trading, LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q4 2021$174,000
-73.6%
14,100
-66.6%
0.01%
-77.3%
Q3 2021$660,000
+1550.0%
42,260
+185.5%
0.02%
+2100.0%
Q2 2021$40,000
-59.2%
14,800
-86.3%
0.00%
-66.7%
Q4 2020$98,000
-76.6%
108,300
-11.4%
0.00%
-85.7%
Q3 2020$418,000
-83.0%
122,300
-87.5%
0.02%
-84.4%
Q2 2020$2,457,000
+7578.1%
981,427
+7508.0%
0.14%
+6650.0%
Q1 2020$32,000
-99.7%
12,900
-99.6%
0.00%
-99.7%
Q4 2019$12,193,000
+1561.2%
3,196,600
+84.7%
0.67%
+1032.2%
Q3 2019$734,000
+280.3%
1,731,100
+746.1%
0.06%
+293.3%
Q2 2019$193,000204,600
+888.4%
0.02%
Q4 2018$0
-100.0%
20,700
-68.4%
0.00%
-100.0%
Q3 2017$338,000
+11166.7%
65,566
+111.5%
0.02%
Q2 2017$3,000
-94.2%
31,000
-2.8%
0.00%
-100.0%
Q1 2017$52,000
-77.4%
31,900
-35.9%
0.00%
-62.5%
Q3 2016$230,00049,8000.01%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 700,000$42,833,0008.57%
SILVERARC CAPITAL MANAGEMENT, LLC 308,819$18,897,0007.82%
Vahanian & Associates Financial Planning Inc. 45,533$2,786,0006.44%
DCF Advisers, LLC 238,500$14,594,0006.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 50,956$20,930,0004.72%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,531,923$93,738,0002.86%
Nicholas Investment Partners, LP 562,373$34,412,0002.45%
Bellevue Group AG 3,429,619$209,859,0002.44%
WASATCH ADVISORS LP 7,477,868$457,571,0002.25%
Quantum Private Wealth, LLC 73,772$4,514,0001.95%
View complete list of INTRA CELLULAR THERAPIES INC shareholders